Onseget 8mg/4ml Injection

Onseget 8mg/4ml Injection contains Ondansetron as its active ingredient. Ondansetron belongs to a class of medications called serotonin 5-HT3 receptor antagonists. It is primarily used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery.

Indications:

Onseget 8mg/4ml Injection is indicated for the prevention of nausea and vomiting associated with:

• Chemotherapy-induced nausea and vomiting (CINV)
• Radiation therapy-induced nausea and vomiting (RINV)
• Postoperative nausea and vomiting (PONV)

Dosage and Administration:

• The recommended dosage of Onseget 8mg/4ml Injection varies depending on the specific indication and patient factors.
• It is administered as a slow intravenous (IV) injection or infusion over a prescribed duration.
• The dosage may be adjusted based on the patient’s response and the severity of symptoms.

Precautions:

• Onseget 8mg/4ml Injection should be used with caution in patients with a history of hypersensitivity reactions to ondansetron or other serotonin 5-HT3 receptor antagonists.
• Patients with underlying cardiac conditions, including QT interval prolongation, should be monitored closely during treatment.
• Use with caution in patients with hepatic impairment, as ondansetron metabolism may be altered.

Contraindications:

• Onseget 8mg/4ml Injection is contraindicated in patients with known hypersensitivity to ondansetron or any components of the formulation.

Side Effects:

Common side effects of Onseget 8mg/4ml Injection may include:

• Headache
• Fatigue
• Constipation
• Diarrhea
• Dizziness
• Flushing
• Injection site reactions
• Transient elevation of liver enzymes

Storage:

• Store Onseget 8mg/4ml Injection at room temperature (20-25°C) away from light and moisture.
• Do not freeze the injection.
• Keep the medication out of reach of children.